XML 103 R42.htm IDEA: XBRL DOCUMENT

Investments In and Advances to Equity Method Investees Investments In and Advances to Equity Method Investees (Tables)

12 Months Ended

Dec. 31, 2019

Equity Method Investments and Joint Ventures [Abstract]

Schedule of carrying value of the associated assets and liabilities and the associated maximum loss exposure for the unconsolidated VIEs

The following table represents the carrying value of the associated assets and liabilities and the associated maximum loss exposure for the unconsolidated VIEs as of the date indicated (in thousands):



	As of December 31, 2019
	Passport Buyer		Momentum Health Group, LLC
Assets:
Current assets	$	271,894	$	50,729
Non current assets	577		39,259
Total assets	$	272,471	$	89,988
Liabilities
Current liabilities	181,206		$	55,442
Non current liabilities	40		44,650
Total liabilities	$	181,246	$	100,092

Investment carrying value	$	70,000	$	46,456
Loan and interest receivable	41,387		—
Guarantee	25,000		—
Maximum exposure	$	136,387	$	46,456

Schedule of summarized equity method investees financial information

The following table represents the aggregated summarized financial information as of and for the dates indicated (in thousands):



	As of December 31,
	2019		2018
Current assets	$	356,085	$	19,698
Non current assets	43,744		67
Current liabilities	267,300		12,748
Noncurrent liabilities	57,599		—
Non controlling interests	70,535		6,608



	For the Year Ended December 31,
	2019			2018			2017
Revenue	$	387,960		$	3,591		$	—
Operating loss	(60,572		)	(13,085		)	—
Net loss	(73,685		)	(13,066		)	—
Net loss attributable to entity	(23,348		)	(4,099		)	—

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details